HighVista Strategies’s Arena Pharmaceuticals Inc ARNA Stock Holding History

HighVista Strategies’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-21,433	Closed	-$1.99M	–	105
2021 Q4	$1.99M	Sell	21,433 -2,425	-10%	-$160K	1.59%	12
2021 Q3	$1.42M	Buy	+23,858	New	+$1.41M	0.94%	20
2021 Q2	–	Sell	-10,656	Closed	-$739K	–	153
2021 Q1	$739K	Sell	10,656 -1,464	-12%	-$113K	0.55%	34
2020 Q4	$931K	Buy	12,120 +4,699	+63%	+$352K	0.59%	32
2020 Q3	$555K	Buy	+7,421	New	+$495K	0.4%	36

HighVista Strategies's ARNA Position: Q1 2022 in Review

HighVista Strategies sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 21,433 shares — an estimated $1.99M sold.

HighVista Strategies first reported a position in ARNA in Q3 2020 and held it in 5 quarters. The position peaked at $1.99M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

HighVista Strategies reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
HighVista Strategies sold 21,433 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $1.99M.
HighVista Strategies first reported a position in Arena Pharmaceuticals Inc in Q3 2020 and held it in 5 quarters.
HighVista Strategies's Arena Pharmaceuticals Inc position peaked at $1.99M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on HighVista Strategies's 13F filing for Q1 2022, filed 16 May 2022.